31 Publications (Page 2 of 2)
2006
Prognostic DNA Methylation Biomarkers in Ovarian Cancer
Wei, Susan H⋅Balch, Curtis⋅Paik, Henry H⋅Kim, Yoo-Sung⋅Baldwin, Rae L⋅Liyanarachchi, Sandya⋅Li, Lang⋅Wang, Zailong⋅Wan, Joseph C⋅Davuluri, Ramana V⋅Karlan, Beth Y⋅Gifford, Gillian⋅Brown, Robert⋅Kim, Sun⋅Huang, Tim H and Nephew, Ken
Clinical Cancer Research, vol. 12, (no. 9), pp. 2788-2794, 2006. | Journal Article
2005
Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Balch, Curtis⋅Balch, Curtis⋅Yan, Pearlly S⋅Yan, Pearlly⋅Craft, Teresa⋅Craft, Teresa⋅Young, Suzanne⋅Young, Suzanne⋅Skalnik, David G⋅Skalnik, David⋅Huang, Tim H⋅Huang, Tim⋅Nephew, Kenneth and Nephew, Ken
Molecular cancer therapeutics, vol. 4, (no. 10), pp. 1505-14, 2005/Oct. | Journal Article
 
New anti-cancer strategies: epigenetic therapies and biomarkers.
Balch, Curtis⋅Montgomery, John S⋅Paik, Hyun-Il⋅Kim, Sun⋅Huang, Tim H and Nephew, Ken
Frontiers in bioscience : a journal and virtual library, vol. 10, pp. 1897-931, 2005. | Journal Article
2004
The epigenetics of ovarian cancer drug resistance and resensitization.
Balch, Curtis⋅Huang, Tim H⋅Brown, Robert and Nephew, Ken
American journal of obstetrics and gynecology, vol. 191, (no. 5), pp. 1552-72, 2004/Nov. | Journal Article
1998
Mutational and crystallographic analyses of interfacial residues in annexin V suggest direct interactions with phospholipid membrane components
Campos, Begoña⋅Mo, YD⋅Mealy, TR⋅Li, CW⋅Swairjo, MA⋅Balch, Curtis⋅Head, James F⋅Retzinger, Gregory⋅Dedman, John R and Seaton, Barbara A
Biochemistry (Washington), vol. 37, (no. 22), pp. 8004-8010, 1998. | Journal Article
1997
Annexins II and V inhibit cell migration.
Balch, Curtis and Dedman, J R
Experimental cell research, vol. 237, (no. 2), pp. 259-63, 1997/Dec/15. | Journal Article